naxitamab Report issue

Biologics mAb Orphan Drug FDA Approved FDA Breakthrough Therapy FDA Accelerated Approval FDA

Active Ingredient History

  • Now

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

United States

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

124i-humanized 3f8 | 131i-3f8 | 3f8 | hu3f8 | mab-3f8 | monoclonal antibody 3f8


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue